Literature DB >> 11434613

Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line.

S Osada1, B I Carr.   

Abstract

BACKGROUND/AIMS: To understand the mechanisms of liver regeneration or hepatoma apoptosis, it is important to estimate the turning point of the signal transduction by growth factor receptor. Since 2-(2-hydroxyethylsulfaryl) 3-methyl-1,4-naphthoquinone or CPD 5 has been shown to mediate the phosphorylation of epidermal growth factor (EGF) receptor in Hep3B hepatoma cells, the differences between EGF and CPD 5-mediated signal transduction were studied.
METHODS: DNA content was measured by Hoechst fluorescent assay. Phosphorylated proteins were described with Western blots or two-dimensional electrophoresis.
RESULTS: CPD 5-induced EGFR phosphorylation was functional to stimulate Ras pathway. However, CPD 5-mediated extracellular signal-regulated kinase (ERK) phosphorylation was not antagonized by inhibition of upstream activation with PD153035. CPD 5 inhibited ERK dephosphorylation in cell lysate, suggesting that ERK phosphorylation by CPD 5 was depending on kinase activity and phosphatase inhibition. Two-dimensional electrophoresis showed extra phospho ERK spot, which was indicated to have close association with CPD 5-induced growth inhibition, since U0126 antagonized growth inhibition and appearance of this spot.
CONCLUSIONS: The turning point of EGFR pathway was proved to have close association with the expressed level of phosphorylated ERK. ERK phosphorylation was suggested to play a critical role in growth factor-induced signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434613     DOI: 10.1016/s0168-8278(00)00102-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  3 in total

1.  Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes.

Authors:  Jianrong Li; Hong Wang; Paul A Rosenberg
Journal:  J Neurosci Res       Date:  2009-07       Impact factor: 4.164

2.  Novel therapy for locally advanced triple-negative breast cancer.

Authors:  Atsuko Yamada; Shinji Osada; Toshiyuki Tanahashi; Satoshi Matsui; Yoshiyuki Sasaki; Yoshihiro Tanaka; Naoki Okumura; Nobuhisa Matsuhashi; Takao Takahashi; Kazuya Yamaguchi; Kazuhiro Yoshida
Journal:  Int J Oncol       Date:  2015-08-05       Impact factor: 5.650

3.  Determining timing of hepatectomy for colorectal cancer with distant metastasis according to imaging-based tumor shrinkage ratio.

Authors:  Yoshiyuki Sasaki; Shinji Osada; Ryuutarou Mori; Hisashi Imai; Yoshihiro Tanaka; Nobuhiro Matsuhashi; Naoki Okumura; Kenichi Nonaka; Takao Takahashi; Kazuhiro Yoshida
Journal:  Int J Med Sci       Date:  2013-08-01       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.